MYDA Advisors’s Advent Technologies ADN Stock Holding History

MYDA Advisors’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,551	Closed	-$481K	–	194
2020 Q3	$481K	Buy	+1,551	New	+$480K	0.25%	80

Other funds holding ADN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return

ACM

Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

MYDA Advisors's ADN Position: Q4 2020 in Review

MYDA Advisors sold out of Advent Technologies (ADN) in Q4 2020, closing a stake of 1,551 shares — an estimated $481K sold.

MYDA Advisors first reported a position in ADN in Q3 2020 and held it in 1 quarter. The position peaked at $481K in Q3 2020. 24 funds tracked by Wall St. Rank hold ADN as of Q4 2020.

MYDA Advisors reported no remaining Advent Technologies position as of Q4 2020 after selling out during the quarter.
MYDA Advisors sold 1,551 Advent Technologies shares in Q4 2020, an estimated $481K.
MYDA Advisors first reported a position in Advent Technologies in Q3 2020 and held it in 1 quarter.
MYDA Advisors's Advent Technologies position peaked at $481K in Q3 2020.
24 funds tracked by Wall St. Rank held Advent Technologies as of Q4 2020.

Based on MYDA Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.